Back
ESC Premium Access

Total thrombus-formation analysis system (T-TAS) can predict target lesion revascularization in patients undergoing endovascular therapy for critical limb ischemia

Session: Peripheral Vascular and Cerebrovascular Disease ePosters
Topic: Peripheral Artery Disease
Speaker: Doctor N. Kuyama (Osaka, JP)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

Like

About the speaker

Doctor Naoto Kuyama

National Cerebral and Cardiovascular Center Hospital, Osaka (Japan)
0 follower

18 more presentations in this session

Impact of polyvascular disease on the prognosis of acute coronary syndrome

Speaker: Professor N. Laraba (Algiers, DZ)

Access
Abstract
Slides
Like
Thumbnail

The efficacy and safety of dual-pathway inhibition therapy among patients with peripheral arterial disease - a meta-analysis

Speaker: Doctor J. Mapili (Manila, PH)

Access
Abstract
Slides
Like
Thumbnail

Temporal course of vascular response after fluoropolymer paclitaxel-eluting stent implantation for femoropopliteal artery lesions

Speaker: Doctor Y. Tomoi (Kitakyushu, JP)

Access
Abstract
Slides
Like
Thumbnail

Pre-dilatation prior to carotid artery stenting in very severe carotid artery stenosis: beneficial or detrimental?

Speaker: Doctor M. Keskin (Istanbul, TR)

Access
Abstract
Slides
Like
Thumbnail

The impact of malnutrition-inflammation-atherosclerosis (MIA) syndrome on the prognosis of elderly patients with chronic limb-threatening ischemia after endovascular therapy

Speaker: Doctor T. Sonoda (Kagoshima, JP)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Peripheral Vascular and Cerebrovascular Disease ePosters

Speakers: Doctor N. Kuyama, Professor N. Laraba, Doctor J. Mapili, Doctor Y. Tomoi, Doctor M. Keskin...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources